Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA5198754
Max Phase: Preclinical
Molecular Formula: C32H26NaO6PS2
Molecular Weight: 602.67
Associated Items:
ID: ALA5198754
Max Phase: Preclinical
Molecular Formula: C32H26NaO6PS2
Molecular Weight: 602.67
Associated Items:
Canonical SMILES: CCOc1cccc2c1Sc1ccccc1C=C2OP(=O)([O-])OC1=Cc2ccccc2Sc2c(OCC)cccc21.[Na+]
Standard InChI: InChI=1S/C32H27O6PS2.Na/c1-3-35-25-15-9-13-23-27(19-21-11-5-7-17-29(21)40-31(23)25)37-39(33,34)38-28-20-22-12-6-8-18-30(22)41-32-24(28)14-10-16-26(32)36-4-2;/h5-20H,3-4H2,1-2H3,(H,33,34);/q;+1/p-1
Standard InChI Key: ABIYBOGWZCKJCZ-UHFFFAOYSA-M
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 602.67 | Molecular Weight (Monoisotopic): 602.0987 | AlogP: 9.24 | #Rotatable Bonds: 8 |
Polar Surface Area: 74.22 | Molecular Species: ACID | HBA: 7 | HBD: 1 |
#RO5 Violations: 2 | HBA (Lipinski): 6 | HBD (Lipinski): 1 | #RO5 Violations (Lipinski): 2 |
CX Acidic pKa: 0.85 | CX Basic pKa: | CX LogP: 7.66 | CX LogD: 5.28 |
Aromatic Rings: 4 | Heavy Atoms: 41 | QED Weighted: 0.20 | Np Likeness Score: 0.01 |
1. Chen LH, Zhang Q, Xiao YF, Fang YC, Xie X, Nan FJ.. (2022) Phosphodiesters as GPR84 Antagonists for the Treatment of Ulcerative Colitis., 65 (5.0): [PMID:35195005] [10.1021/acs.jmedchem.1c01813] |
Source(1):